A detailed history of Wilkins Investment Counsel Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Wilkins Investment Counsel Inc holds 3,044 shares of LLY stock, worth $2.42 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
3,044
Previous 3,104 1.93%
Holding current value
$2.42 Million
Previous $2.81 Million 4.06%
% of portfolio
0.38%
Previous 0.42%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $46,328 - $57,601
-60 Reduced 1.93%
3,044 $2.7 Million
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $173,968 - $218,169
240 Added 8.38%
3,104 $2.81 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $1.12 Million - $1.49 Million
1,886 Added 192.84%
2,864 $2.23 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $11,554 - $13,620
-22 Reduced 2.2%
978 $570,000
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $160,839 - $221,740
-370 Reduced 27.01%
1,000 $537,000
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $63,133 - $84,416
-180 Reduced 11.61%
1,370 $642,000
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $31,063 - $36,482
-100 Reduced 6.06%
1,550 $532,000
Q3 2022

Nov 08, 2022

SELL
$296.48 - $337.87 $88,944 - $101,361
-300 Reduced 15.38%
1,650 $534,000
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $23,469 - $29,166
-100 Reduced 4.88%
1,950 $558,000
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $99,720 - $122,719
-450 Reduced 18.0%
2,050 $474,000
Q2 2020

Aug 10, 2020

SELL
$136.42 - $164.18 $13,641 - $16,418
-100 Reduced 3.85%
2,500 $410,000
Q3 2019

Nov 08, 2019

SELL
$106.79 - $116.16 $25,629 - $27,878
-240 Reduced 8.45%
2,600 $291,000
Q2 2017

Aug 10, 2017

BUY
N/A
2,840
2,840 $234,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wilkins Investment Counsel Inc Portfolio

Follow Wilkins Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilkins Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wilkins Investment Counsel Inc with notifications on news.